Patents/Assignees

Navidea Biopharmaceuticals, Inc.

9 patents in portfolio

US12583945utility2026
Synthesis of Uniformly Defined Molecular Weight Mannosylated Dextrans and Derivatives Thereof
0 cites
US12404349utility2025
Amide Linkages of Sugar Moieties to Amine Terminated Leashes Attached to Carbohydrate Polymers
0 cites
US12297222utility2025
CD206 Targeted Drug Delivery Vehicles Carrying Novel Bisphosphonate Drug Payloads via a Degradable Linker
0 cites
US12178829utility2024
Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking
0 cites
US12005122utility2024
Compounds and Methods for Diagnosis and Treatment of Viral Infections
0 cites
US12006339utility2024
CD206 Targeted Drug Delivery Vehicles Carrying Novel Bisphosphonate Drug Payloads via a Degradable Linker
0 cites
US11859023utility2024
Synthesis of Uniformly Defined Molecular Weight Mannosylated Dextrans and Derivatives Thereof
0 cites
US11833170utility2023
Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking
0 cites
US11590236utility2023
Compositions and Methods for Altering Macrophage Phenotype
0 cites